These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2265027)

  • 21. Defective nef alleles in a cohort of hemophiliacs with progressing and nonprogressing HIV-1 infection.
    Brambilla A; Turchetto L; Gatti A; Bovolenta C; Veglia F; Santagostino E; Gringeri A; Clementi M; Poli G; Bagnarelli P; Vicenzi E
    Virology; 1999 Jul; 259(2):349-68. PubMed ID: 10388660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification and characterization of human immunodeficiency virus type 1 nef gene product expressed by a recombinant baculovirus.
    Matsuura Y; Maekawa M; Hattori S; Ikegami N; Hayashi A; Yamazaki S; Morita C; Takebe Y
    Virology; 1991 Oct; 184(2):580-6. PubMed ID: 1909480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epitope mapping of murine monoclonal antibodies against human immunodeficiency virus type 1 Nef.
    Otake K; Fujii Y; Tashiro M; Adachi A; Kitoh J
    Exp Anim; 1997 Jan; 46(1):53-8. PubMed ID: 9027472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody-dependent cellular cytotoxicity via humoral immune epitope of Nef protein expressed on cell surface.
    Yamada T; Watanabe N; Nakamura T; Iwamoto A
    J Immunol; 2004 Feb; 172(4):2401-6. PubMed ID: 14764710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users.
    Rezza G; Titti F; Pezzotti P; Sernicola L; Lo Caputo S; Angarano G; Lazzarin A; Sinicco A; Rossi GB; Verani P
    J Biol Regul Homeost Agents; 1992; 6(1):15-20. PubMed ID: 1359736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of anti-p27nef antibody detection in HIV-seronegative high-risk people.
    Gluckman JC; Fretz-Foucault C; Rouzioux C; Perret P; Lopez O; Bucquet D; Bahraoui E
    AIDS; 1989 Dec; 3(12):855-6. PubMed ID: 2517205
    [No Abstract]   [Full Text] [Related]  

  • 27. [The expression of a fragment of the HIV-1 Nef gene in Escherichia coli bacteria].
    Garaev MM; Bobkov AF; Taĭ MKh; Kazennova EV
    Vopr Virusol; 1991; 36(1):17-8. PubMed ID: 1713370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibodies against a synthetic peptide from human immunodeficiency virus type 1 Nef protein.
    Steinaa L; Wulff AM; Saermark T
    Hybridoma; 1994 Oct; 13(5):383-8. PubMed ID: 7860095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection of monkeys vaccinated with vpr- and/or nef-defective simian immunodeficiency virus strain mac/human immunodeficiency virus type 1 chimeric viruses: a potential candidate live-attenuated human AIDS vaccine.
    Igarashi T; Ami Y; Yamamoto H; Shibata R; Kuwata T; Mukai R; Shinohara K; Komatsu T; Adachi A; Hayami M
    J Gen Virol; 1997 May; 78 ( Pt 5)():985-9. PubMed ID: 9152414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-CD4 antibodies are associated with HIV-1 seroconversion and may be detectable before anti-HIV-1 antibodies. The Multicenter AIDS Cohort Study.
    Keiser P; Keay S; Wasserman S; Wecksler W
    AIDS Res Hum Retroviruses; 1992 Nov; 8(11):1919-27. PubMed ID: 1489580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreasing levels of anti-Nef antibody correlate with increasing HIV type 1 viral loads and AIDS disease progression.
    Chen YM; Lin RH; Lee CM; Fu CY; Chen SC; Syu WJ
    AIDS Res Hum Retroviruses; 1999 Jan; 15(1):43-50. PubMed ID: 10024051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Course of specific T lymphocyte cytotoxicity, plasma and cellular viral loads, and neutralizing antibody titers in 17 recently seroconverted HIV type 1-infected patients.
    Legrand E; Pellegrin I; Neau D; Pellegrin JL; Ragnaud JM; Dupon M; Guillemain B; Fleury HJ
    AIDS Res Hum Retroviruses; 1997 Nov; 13(16):1383-94. PubMed ID: 9359658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nef and Gag synthetic peptide priming of antibody responses to HIV type 1 antigens in mice and primates.
    Vaslin B; Claverie JM; Benveniste O; Barre-Sinoussi FC; Dormont D
    AIDS Res Hum Retroviruses; 1994 Oct; 10(10):1241-50. PubMed ID: 7531460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune responses to human immunodeficiency virus type 1 in exposed but uninfected individuals: protection or chance?
    Looney DJ
    J Clin Invest; 1994 Mar; 93(3):920. PubMed ID: 8132777
    [No Abstract]   [Full Text] [Related]  

  • 35. Persistent antibody response to the HIV-1-negative regulatory factor in HIV-1-infected seronegative persons.
    Ameisen JC; Guy B; Chamaret S; Loche M; Mach B; Tartar A; Mouton Y; Capron A
    N Engl J Med; 1989 Jan; 320(4):251-2. PubMed ID: 2783476
    [No Abstract]   [Full Text] [Related]  

  • 36. Speed of progression to AIDS and degree of antibody response to accessory gene products of HIV-1.
    Reiss P; Lange JM; de Ronde A; de Wolf F; Dekker J; Debouck C; Goudsmit J
    J Med Virol; 1990 Mar; 30(3):163-8. PubMed ID: 2341832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccine-induced HIV seropositivity: a problem on the rise.
    Van Braeckel E; Koutsoukos M; Bourguignon P; Clement F; McNally L; Leroux-Roels G
    J Clin Virol; 2011 Apr; 50(4):334-7. PubMed ID: 21300566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study of the antigenic structure of human immunodeficiency virus using synthetic peptides].
    Ivanov VS; Chikin LD; Suvorova ZK; Kozhich AT; Ivanov VT
    Bioorg Khim; 1992 Jun; 18(6):784-93. PubMed ID: 1384509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV excretion patterns and specific antibody responses in body fluids.
    O'Shea S; Cordery M; Barrett WY; Richman DD; Bradbeer C; Banatvala JE
    J Med Virol; 1990 Aug; 31(4):291-6. PubMed ID: 2125310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low antigenicity of HIV-1 rev: rev-specific antibody response of limited value as correlate of rev gene expression and disease progression.
    Reiss P; De Ronde A; Lange JM; De Wolf F; Dekker J; Danner SA; Debouck C; Goudsmit J
    AIDS Res Hum Retroviruses; 1989 Dec; 5(6):621-8. PubMed ID: 2692659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.